Ocular Therapeutix, Inc.
NASDAQ:OCUL
7.72 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 392.102 | 195.807 | 102.3 | 164.164 | 228.057 | 54.437 | 54.062 | 41.538 | 32.936 | 30.784 | 37.393 | 17.505 | 23.854 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35.209 | 74.28 | 37.435 | 0 | 0 |
| Cash and Short Term Investments
| 392.102 | 195.807 | 102.3 | 164.164 | 228.057 | 54.437 | 54.062 | 41.538 | 68.145 | 105.064 | 74.828 | 17.505 | 23.854 |
| Net Receivables
| 32.388 | 26.179 | 21.325 | 21.135 | 12.252 | 2.548 | 0.201 | 0.226 | 0.25 | 0.193 | 0.329 | 0.269 | 0.045 |
| Inventory
| 3.04 | 2.305 | 1.974 | 1.25 | 1.201 | 0.954 | 0.217 | 0.122 | 0.113 | 0.134 | 0.133 | 0 | 0 |
| Other Current Assets
| 13.457 | 7.944 | 4.028 | 9.502 | 8.044 | 4.462 | 3.426 | 1.453 | 2.78 | 3.184 | 0.893 | 0.24 | 0.726 |
| Total Current Assets
| 440.987 | 232.235 | 129.627 | 191.3 | 246.16 | 60.17 | 56.193 | 43.339 | 69.898 | 106.983 | 76.183 | 18.014 | 24.262 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 15.334 | 18.211 | 17.898 | 11.823 | 13.939 | 16.806 | 10.236 | 10.478 | 3.313 | 3.095 | 1.782 | 0.904 | 0.785 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 1.764 | 1.764 | 1.764 | 1.764 | 6.614 | 1.614 | 1.728 | 0.228 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.614 | 1.614 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.228 | 0.228 | 0.238 |
| Total Non-Current Assets
| 16.948 | 19.825 | 19.662 | 13.587 | 15.703 | 18.57 | 16.85 | 12.092 | 5.041 | 3.323 | 2.01 | 1.132 | 1.023 |
| Total Assets
| 457.935 | 252.06 | 149.289 | 204.887 | 261.863 | 78.74 | 73.043 | 55.431 | 74.939 | 110.306 | 78.193 | 19.146 | 25.285 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 4.176 | 4.389 | 5.123 | 4.592 | 2.709 | 3.268 | 2.965 | 3.571 | 2.116 | 1.957 | 1.316 | 0.545 | 0.583 |
| Short Term Debt
| 1.933 | 1.586 | 3.198 | 3.248 | 11.006 | 2.252 | 0 | 5.545 | 1.549 | 0 | 1.354 | 1.806 | 1.806 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.128 | 0.255 | 0.576 | 13 | 12 | 0 | 0 | 0 | 0 | 0.042 | 0.188 | 0.25 | 0 |
| Other Current Liabilities
| 35.117 | 28.666 | 22.498 | 18.497 | 12.949 | 6.509 | 6.194 | 4.31 | 4.635 | 3.379 | 3.016 | 0.741 | 1.086 |
| Total Current Liabilities
| 41.354 | 34.896 | 31.395 | 26.337 | 26.664 | 12.029 | 9.159 | 13.426 | 8.3 | 5.378 | 5.874 | 3.342 | 3.475 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 73.85 | 81.803 | 62.684 | 57.359 | 48.791 | 58.217 | 24.788 | 12.471 | 14.094 | 15.272 | 13.511 | 0.651 | 2.259 |
| Deferred Revenue Non-Current
| 0 | 14.135 | 13.387 | 13 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 27.387 | 30.095 | 6.444 | 20.192 | 98.313 | 12.124 | 3.221 | 3.387 | 0.537 | 0.068 | 0.112 | 74.625 | 66.162 |
| Total Non-Current Liabilities
| 101.237 | 126.033 | 82.515 | 90.551 | 159.104 | 70.341 | 28.009 | 15.858 | 14.631 | 15.34 | 13.623 | 75.276 | 68.421 |
| Total Liabilities
| 142.591 | 160.929 | 113.91 | 116.888 | 185.768 | 82.37 | 37.168 | 29.284 | 22.931 | 20.718 | 19.497 | 78.618 | 71.896 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 78.193 | 74.344 | 65.823 |
| Common Stock
| 0.016 | 0.012 | 0.008 | 0.008 | 0.008 | 0.005 | 0.004 | 0.003 | 0.003 | 0.002 | 0.002 | 0 | 0 |
| Retained Earnings
| -891.084 | -697.578 | -616.842 | -545.804 | -539.251 | -383.615 | -297.243 | -237.265 | -173.879 | -129.176 | -89.428 | -60.78 | -47.463 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.005 | -0.068 | -2.221 | -1.675 | -1.271 |
| Other Total Stockholders Equity
| 1,206.412 | 788.697 | 652.213 | 633.795 | 615.338 | 379.98 | 333.114 | 263.409 | 225.889 | 218.83 | 148.122 | 2.983 | -64.971 |
| Total Shareholders Equity
| 315.344 | 91.131 | 35.379 | 87.999 | 76.095 | -3.63 | 35.875 | 26.147 | 52.008 | 89.588 | 58.696 | -59.472 | -46.611 |
| Total Equity
| 315.344 | 91.131 | 35.379 | 87.999 | 76.095 | -3.63 | 35.875 | 26.147 | 52.008 | 89.588 | 58.696 | -59.472 | -46.611 |
| Total Liabilities & Shareholders Equity
| 457.935 | 252.06 | 149.289 | 204.887 | 261.863 | 78.74 | 73.043 | 55.431 | 74.939 | 110.306 | 78.193 | 19.146 | 25.285 |